Sclerosing encapsulating peritonitis (SEP), or abdominal cocoon is a rare cause of intestinal obstruction, and still etiology remains unknown. We report a series of 4 patients with abdominal cocoon, and all the 4 patients had previously undergone living-donor liver transplantation (LDLT). There was no evidence of SEP before and during LDLT. At the time of diagnosis of SEP, 3 out of 4 patients had ascites. First and fourth patients had multiple episodes or attacks of cholangitis, which were managed by percutaneous transhepatic biliary drainage and hepaticojejunostomy, respectively. All 4 patients presented with intestinal obstruction and 3 of them underwent a successful operation. The fourth patient died due to liver failure and complications of the SEP. The first 3 patients are doing well without SEP recurrence. Our experience suggest that the prognosis of SEP is poor in patients with poor graft liver functions after LDLT. (Ann Hepatobiliary Pancreat Surg 2018;22:144-149)
INTRODUCTION
Sclerosing encapsulating peritonitis (SEP), or abdominal cocoon is a rare clinical condition which can lead to bowel obstruction, and its etiology is still unclear. The dense fibrocollagenous membrane, which forms several cocoons, frequently encases small bowel either partially or totally. 1 Reported cases of SEP were mostly noted in patients undergoing peritoneal dialysis (PD), 2, 3 end-stage liver disease (ESLD) with ascites, liver transplantation (LT), [4] [5] [6] [7] [8] [9] and in cirrhotic patients after peritoneal-venous shunting (PVS). 10 SEP has also been reported in adolescent females, the occurrence of which is potentially linked to retrograde menstruation and in patients on -blockers treatment. 11, 12 Usually, SEP is diagnosed at the time of laparotomy. Early diagnosis can be made with preoperative abdominal computed tomography (CT) scan. We herein report 4 patients with SEP, who developed SEP after living-donor LT (LDLT). Three patients were successfully treated with adhesiolysis and partial small bowel resection. Unfortunately, the fourth patient developed SEP due to chronic liver disease secondary to hepatitis C virus (HCV) recurrence while he was waiting for retransplantation. His liver function was very poor, and condition was too risky to perform any surgical intervention. The patient died from liver failure and SEP complication.
The patients provided written informed consent before the initiation of the study, which was approved by the Ethics Committee of Kyoto University in accordance with the Declaration of Helsinki of 1996.
CASE

Case 1
A 62-years-old man had hepatocellular carcinoma
Fig. 1.
Abdominal computed tomography (CT) scan reveals remarkable ascites, thickening of the peritoneum and fibrous sheaths surrounding the small intestine, and presence of a mechanical intestinal obstruction.
Fig. 2.
On laparotomy, the small intestine appears to be encapsulated with a fibrous peel (A). We removed the fibrous membrane, and a total enteroclysis was performed (B). CT scan findings were consistent with SEP. On laparotomy, we found the small intestine encapsulated by a fibrous membrane. We removed the fibrous membrane, and subsequently, total adhesiolysis and enteroclysis were performed ( Fig. 2A, B) . The postoperative course was uneventful, and the patient was discharged. CT scan also showed the presence of a fibrous sheath around the intestine with intestinal dilatation (Fig. 5 ).
Case 2
According to these findings, a diagnosis of the abdominal cocoon was made. We considered doing a surgical intervention but the liver function and clinical condition of the patient worsened and unfortunately, we lost the patient. One patient died due to intracerebral infarction and pulmonary aspiration. Mortality rate was 20%. However, a specific pre-LT history with regards to ascites or SBP was not illustrated. It is hypothesized that such conditions could play a substantial role in the pathogenesis of SEP.
The second case series published by Mekeel et al described 3 SEP cases, of which one case was a retransplantation. 5 One patient was diagnosed with SEP during LT, and the other 2 cases were diagnosed 4 and 5 months after LT, respectively. However, a pre-LT history of refractory ascites, multiple paracentesis, and SBP was reported in this series. Two patients had encasement of their grafts, which subsequently resulted in biliary and outflow obstruction. Adhesiolysis was performed in all the cases but unfortunately, the mortality rate was 100%.
Causes of mortality were sepsis and multiorgan failure. Tamoxifen was occasionally used as a therapeutic option in 4 SEP cases. 13 Moustafellos et al., 14 reported that tamoxifen treatment led to improvement in SEP in 2 cases, diagnosed after kidney transplantation. Tamoxifen probably interferes with transforming growth factor beta-1
(TGF-beta-1) and is thus regarded as potentially useful in the treatment of SEP. 15 Reaching to preoperative diagnosis of SEP could be puzzling. High threshold of suspicion is required.
Abdominal CT scans are pivotal. The prognosis for SEP is poor in patients with poor graft liver functions which need to be optimized prior to prompt surgical adhesiolysis. Endoscopic drainage might be better than PTBD for management of biliary stricture with respect to SEP prevention.
